A PPARγ transcriptional cascade directs adipose progenitor cell-niche interaction and niche expansion
暂无分享,去创建一个
M. Kyba | J. Graff | Yuwei Jiang | D. C. Berry | Wei Tang | Robert W Arpke | Daniel C. Berry | A. Jo
[1] A. Salmina,et al. Plasticity of Adipose Tissue-Derived Stem Cells and Regulation of Angiogenesis , 2018, Front. Physiol..
[2] M. Mohammadi,et al. Faculty Opinions recommendation of Additive effects of PDGF receptor beta signaling pathways in vascular smooth muscle cell development. , 2018, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.
[3] M. Kumari,et al. Warming Induces Significant Reprogramming of Beige, but Not Brown, Adipocyte Cellular Identity. , 2018, Cell metabolism.
[4] Tiffany DeSouza,et al. Generation of Functional Human Adipose Tissue in Mice from Primed Progenitor Cells , 2018, bioRxiv.
[5] P. Scherer,et al. VEGF-A–Expressing Adipose Tissue Shows Rapid Beiging and Enhanced Survival After Transplantation and Confers IL-4–Independent Metabolic Improvements , 2017, Diabetes.
[6] J. Graff,et al. Emerging Roles of Adipose Progenitor Cells in Tissue Development, Homeostasis, Expansion and Thermogenesis , 2016, Trends in Endocrinology & Metabolism.
[7] K. Alitalo,et al. VEGFB/VEGFR1-Induced Expansion of Adipose Vasculature Counteracts Obesity and Related Metabolic Complications. , 2016, Cell metabolism.
[8] May-yun Wang,et al. Pdgfrβ+ Mural Preadipocytes Contribute to Adipocyte Hyperplasia Induced by High-Fat-Diet Feeding and Prolonged Cold Exposure in Adult Mice. , 2016, Cell metabolism.
[9] J. Graff,et al. Mouse strains to study cold-inducible beige progenitors and beige adipocyte formation and function , 2016, Nature Communications.
[10] Zhiyu Zhao,et al. Deep imaging of bone marrow shows non-dividing stem cells are mainly perisinusoidal , 2015, Nature.
[11] B. Öksüzoğlu,et al. Sunitinib-induced severe hypoglycemia in a diabetic patient , 2014, Journal of Oncology Pharmacy Practice.
[12] J. Graff,et al. Independent stem cell lineages regulate adipose organogenesis and adipose homeostasis. , 2014, Cell reports.
[13] N. Noy,et al. Holo-retinol-binding protein and its receptor STRA6 drive oncogenic transformation. , 2014, Cancer research.
[14] P. Rojas-Ríos,et al. Concise Review: The Plasticity of Stem Cell Niches: A General Property Behind Tissue Homeostasis and Repair , 2014, Stem cells.
[15] A. Herman,et al. Inhibition of c-Kit Is Not Required for Reversal of Hyperglycemia by Imatinib in NOD Mice , 2014, PloS one.
[16] S. Morrison,et al. The bone marrow niche for haematopoietic stem cells , 2014, Nature.
[17] Panteleimon Rompolas,et al. Spatial organization within a niche as a determinant of stem cell fate , 2013, Nature.
[18] J. Graff,et al. The developmental origins of adipose tissue , 2013, Development.
[19] P. Scherer,et al. Tracking adipogenesis during white adipose tissue development, expansion and regeneration , 2013, Nature Medicine.
[20] J. Graff,et al. SnapShot: Adipocyte Life Cycle , 2012, Cell.
[21] M. Breccia,et al. Fasting glucose level reduction induced by imatinib in chronic myeloproliferative disease with TEL-PDGFRβ rearrangement and type 1 diabetes , 2012, Annals of Hematology.
[22] N. Noy,et al. Retinoic Acid Upregulates Preadipocyte Genes to Block Adipogenesis and Suppress Diet-Induced Obesity , 2012, Diabetes.
[23] J. Graff,et al. Wnt signaling activation in adipose progenitors promotes insulin-independent muscle glucose uptake. , 2012, Cell metabolism.
[24] G. Semenza,et al. Hypoxia-Inducible Factors in Physiology and Medicine , 2012, Cell.
[25] M. Kyba,et al. Inducible Cassette Exchange: A Rapid and Efficient System Enabling Conditional Gene Expression in Embryonic Stem and Primary Cells , 2011, Stem cells.
[26] C. Lynch,et al. Effect of the tyrosine kinase inhibitors (sunitinib, sorafenib, dasatinib, and imatinib) on blood glucose levels in diabetic and nondiabetic patients in general clinical practice , 2011, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.
[27] P. Hauschka,et al. Adipose stem cells originate from perivascular cells , 2011, Biology of the cell.
[28] C. Betsholtz,et al. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. , 2011, Developmental cell.
[29] J. Graff,et al. Thiazolidinediones regulate adipose lineage dynamics. , 2011, Cell metabolism.
[30] Philippe Soriano,et al. PDGFRβ signaling regulates mural cell plasticity and inhibits fat development. , 2011, Developmental cell.
[31] C. Betsholtz,et al. Pericytes and the blood-brain barrier: recent advances and implications for the delivery of CNS therapy. , 2011, Therapeutic delivery.
[32] H. Clevers,et al. Tissue-resident adult stem cell populations of rapidly self-renewing organs. , 2010, Cell stem cell.
[33] B. Desvergne,et al. PPARgamma in placental angiogenesis. , 2010, Endocrinology.
[34] S. Morrison,et al. An in vivo model to study and manipulate the hematopoietic stem cell niche. , 2010, Blood.
[35] Zev Rosenwaks,et al. Engraftment and reconstitution of hematopoiesis is dependent on VEGFR2-mediated regeneration of sinusoidal endothelial cells. , 2009, Cell stem cell.
[36] P. Chambon,et al. Efficient temporally‐controlled targeted mutagenesis in smooth muscle cells of the adult mouse , 2009, Genesis.
[37] R. Hammer,et al. White Fat Progenitor Cells Reside in the Adipose Vasculature , 2008, Science.
[38] J. García-Verdugo,et al. A specialized vascular niche for adult neural stem cells. , 2008, Cell stem cell.
[39] S. Corvera,et al. Enhanced angiogenesis in obesity and in response to PPARgamma activators through adipocyte VEGF and ANGPTL4 production. , 2008, American journal of physiology. Endocrinology and metabolism.
[40] Peter Tontonoz,et al. Fat and beyond: the diverse biology of PPARgamma. , 2008, Annual review of biochemistry.
[41] E. Gaetani,et al. Selective Activation of Peroxisome Proliferator–Activated Receptor (PPAR)α and PPARγ Induces Neoangiogenesis Through a Vascular Endothelial Growth Factor–Dependent Mechanism , 2008, Diabetes.
[42] Sean J. Morrison,et al. Stem Cells and Niches: Mechanisms That Promote Stem Cell Maintenance throughout Life , 2008, Cell.
[43] S. Morrison,et al. Maintaining hematopoietic stem cells in the vascular niche. , 2006, Immunity.
[44] Jill M Seargent,et al. GW9662, a potent antagonist of PPARγ, inhibits growth of breast tumour cells and promotes the anticancer effects of the PPARγ agonist rosiglitazone, independently of PPARγ activation , 2004, British journal of pharmacology.
[45] F. Mandelli,et al. Imatinib mesylate may improve fasting blood glucose in diabetic Ph+ chronic myelogenous leukemia patients responsive to treatment. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[46] W. Wahli,et al. The Direct Peroxisome Proliferator-activated Receptor Target Fasting-induced Adipose Factor (FIAF/PGAR/ANGPTL4) Is Present in Blood Plasma as a Truncated Protein That Is Increased by Fenofibrate Treatment* , 2004, Journal of Biological Chemistry.
[47] Philippe Soriano,et al. Additive Effects of PDGF Receptor β Signaling Pathways in Vascular Smooth Muscle Cell Development , 2003, PLoS biology.
[48] C. Handschin,et al. NUBIScan, an in silico approach for prediction of nuclear receptor response elements. , 2002, Molecular endocrinology.
[49] P. Carmeliet,et al. A novel role for VEGF in endocardial cushion formation and its potential contribution to congenital heart defects. , 2001, Development.
[50] R. Hammer,et al. Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. , 2001, Developmental biology.
[51] 任艳,et al. 胰岛素增敏剂一Thiazolidinediones研究现状 , 2000 .
[52] P. Chambon,et al. Characterization of the Fasting-induced Adipose Factor FIAF, a Novel Peroxisome Proliferator-activated Receptor Target Gene* , 2000, The Journal of Biological Chemistry.
[53] I. Weissman,et al. Stem Cells Units of Development, Units of Regeneration, and Units in Evolution , 2000, Cell.
[54] G. Mcmahon,et al. Design, synthesis, and evaluations of substituted 3-[(3- or 4-carboxyethylpyrrol-2-yl)methylidenyl]indolin-2-ones as inhibitors of VEGF, FGF, and PDGF receptor tyrosine kinases. , 1999, Journal of medicinal chemistry.
[55] K. Chien,et al. PPARγ Is Required for Placental, Cardiac, and Adipose Tissue Development , 1999 .
[56] A. Whetton,et al. Homing and mobilization in the stem cell niche. , 1999, Trends in cell biology.
[57] K. Umesono,et al. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. , 1998, The Journal of clinical investigation.
[58] Philippe Soriano,et al. Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice. , 1994, Genes & development.
[59] B. Spiegelman,et al. mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. , 1994, Genes & development.
[60] M. Lazar,et al. Peroxisome proliferator and retinoid signaling pathways co-regulate preadipocyte phenotype and survival. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[61] C. Heldin,et al. Coexpression of the platelet-derived growth factor (PDGF) B chain and the PDGF beta receptor in isolated pancreatic islet cells stimulates DNA synthesis. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[62] M. M. Copeland. Recent Results in Cancer Research, Fortschritte der Krebsforschung Progrès dans les Recherches sur le Cancer, Vol 13, Tumours in Children. , 1969 .
[63] C. Waller,et al. Imatinib mesylate. , 2010, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[64] Nuclear Receptor BioMed Central , 2005 .
[65] R. Evans,et al. PPAR gamma is required for placental, cardiac, and adipose tissue development. , 1999, Molecular cell.
[66] T. Meyer,et al. Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative. , 1996, Cancer research.
[67] R. Schofield. The relationship between the spleen colony-forming cell and the haemopoietic stem cell. , 1978, Blood cells.